Länsförsäkringar Multistrategi vs UBS Lux Equity Fund Biotech USD

Länsförsäkringar Multistrategi vs UBS Lux Equity Fund Biotech USD

1. Länsförsäkringar Multistrategi

  • Security

    Länsförsäkringar Multistrategi

  • Fee

    1.20%

  • ISIN

    SE0008962914

  • Holdings

    7

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 7 holdings in Länsförsäkringar Multistrategi, where the largest holding is Schroder Investment Fund Flexible Cat Bond A Acc USD (10.58), followed by SEB FRN Fond A (8.96) and Enter Cross Credit A (7.96). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Länsförsäkringar Multistrategi and UBS Lux Equity Fund Biotech USD.

Länsförsäkringar Multistrategi UBS Lux Equity Fund Biotech USD
1. Schroder Investment Fund Flexible Cat Bond A Acc USD
UK
10.58 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. SEB FRN Fond A
Sweden
8.96 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Enter Cross Credit A
Sweden
7.96 %
3. Moderna Inc
9.21 %
4. iShares Physical Gold ETC
Ireland
3.21 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Rheinmetall AG
Germany
0.66 %
5. AbbVie Inc
USA
5.52 %
6. Roche Holding AG
Switzerland
0.65 %
6. Gilead Sciences Inc
USA
4.66 %
7. Iberdrola SA
Spain
0.6 %
7. Amgen Inc
4.32 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 17, 2025.